Anti-tumor workshop passed GMP certification
Renamed as Heilongjiang Fuhe Pharmaceutical Group Co., Ltd
Build a self operated business team
Investment and construction of a new raw material factory covering an area of 140000 square meters
Fuhe Huaxing Pharmaceutical achieved a revenue of 370 million yuan and a total profit of 75 million yuan
Formally renamed as Heilongjiang Fuhe Huaxing Pharmaceutical Group Co., Ltd
Domestically leading the development of a national second-class asthma relief drug, doxorubicin (Ansema) ®), Becoming the manufacturer with the most complete range of Doxophylline dosage forms in China
Renamed as Heilongjiang Zhaodong Huaxing Pharmaceutical Co., Ltd., it was one of the first 40 joint-stock reform enterprises in the province at that time
Zhaodong Pharmaceutical Factory Established